We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

27 hedge funds and large institutions have $132M invested in Bicycle Therapeutics in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 18 → 27 (+9)

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7.35% less ownership

Funds ownership: 41.74% → 34.39% (-7.3%)

8% less capital invested

Capital invested by funds: $144M → $132M (-$12M)

Holders
27
Holders Change
+9
Holders Change %
+50%
% of All Funds
0.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
6
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Axa
Axa
France
+$2.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.44M
3
MAP
Moody Aldrich Partners
Massachusetts
+$1.41M
4
MWNA
Marshall Wace North America
New York
+$629K
5
Citadel Advisors
Citadel Advisors
Florida
+$561K

Top Sellers

Rank Fund Capital Flow
1
AVA
Atlas Venture Advisors
Massachusetts
-$13.4M
2
Osaic Holdings
Osaic Holdings
Arizona
-$77K
3
Morgan Stanley
Morgan Stanley
New York
-$9.98K
4
California Public Employees Retirement System
California Public Employees Retirement System
California
-$7.72K
5
UBS Group
UBS Group
Switzerland
-$5.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tybourne Capital Management
Hong Kong
$35.1M – – –
SHI
2
SV Health Investors
Massachusetts
$34.4M – – –
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$25.8M +$1.44M +74,425 +5%
AVA
4
Atlas Venture Advisors
Massachusetts
$11M -$13.4M -694,269 -53%
SC
5
Samlyn Capital
New York
$7.86M +$377K +19,552 +5%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$3.79M – – –
Victory Capital Management
7
Victory Capital Management
Texas
$3.04M +$338K +17,520 +12%
Axa
8
Axa
France
$2.6M +$2.8M +144,997 New
Renaissance Technologies
9
Renaissance Technologies
New York
$1.46M +$419K +21,700 +36%
MAP
10
Moody Aldrich Partners
Massachusetts
$1.31M +$1.41M +72,993 New
LCM
11
Laurion Capital Management
New York
$1.04M – – –
Verition Fund Management
12
Verition Fund Management
Connecticut
$607K +$54.1K +2,803 +9%
MWNA
13
Marshall Wace North America
New York
$585K +$629K +32,567 New
Citadel Advisors
14
Citadel Advisors
Florida
$521K +$561K +29,035 New
Osaic Holdings
15
Osaic Holdings
Arizona
$397K -$77K -3,988 -15%
Two Sigma Investments
16
Two Sigma Investments
New York
$366K +$394K +20,399 New
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$358K -$7.72K -400 -2%
Millennium Management
18
Millennium Management
New York
$259K +$18.6K +961 +7%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$238K +$256K +13,270 New
US Bancorp
20
US Bancorp
Minnesota
$235K +$252K +13,073 New
PCM
21
Pentwater Capital Management
Florida
$215K – – –
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$205K +$221K +11,431 New
Morgan Stanley
23
Morgan Stanley
New York
$62K -$9.98K -517 -13%
CAPTRUST Financial Advisors
24
CAPTRUST Financial Advisors
North Carolina
$54K +$57.9K +3,000 New
UBS Group
25
UBS Group
Switzerland
$4K -$5.04K -261 -53%
1
2

BCYC Hedge Fund Activity: Q4 2020 in Review

27 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q4 2020, worth a combined $132M — down 8.4% from $144M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BCYC positions and 0 closed out — a net gain of 10 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Axa, opening a new position worth an estimated $2.8M. The largest seller was Atlas Venture Advisors, cutting an estimated $13.4M.

  • 27 institutional investors held Bicycle Therapeutics (BCYC) as of Q4 2020, up from 18 in Q3 2020.
  • Funds reported $132M of Bicycle Therapeutics stock for Q4 2020, down 8.4% quarter-over-quarter.
  • 10 funds opened new Bicycle Therapeutics positions in Q4 2020 and 0 closed out, a net change of +10 holders.
  • The largest Bicycle Therapeutics buyer in Q4 2020 was Axa, an estimated $2.8M added.
  • The largest Bicycle Therapeutics seller in Q4 2020 was Atlas Venture Advisors, an estimated $13.4M sold.

Based on aggregated 13F filings for Q4 2020.